Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingredion (INGR) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Ingredion (INGR) over the last 13 years, with Q4 2025 value amounting to -$2.0 million.

  • Ingredion's Gains from Investment Securities rose 3333.33% to -$2.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $3.0 million for FY2025, which is 0.0% changed from last year.
  • Latest data reveals that Ingredion reported Gains from Investment Securities of -$2.0 million as of Q4 2025, which was up 3333.33% from $2.0 million recorded in Q3 2025.
  • In the past 5 years, Ingredion's Gains from Investment Securities registered a high of $14.0 million during Q2 2021, and its lowest value of -$5.0 million during Q4 2023.
  • For the 5-year period, Ingredion's Gains from Investment Securities averaged around $1.2 million, with its median value being $1.0 million (2021).
  • As far as peak fluctuations go, Ingredion's Gains from Investment Securities tumbled by 50000.0% in 2022, and later surged by 26666.67% in 2025.
  • Over the past 5 years, Ingredion's Gains from Investment Securities (Quarter) stood at $1.0 million in 2021, then tumbled by 200.0% to -$1.0 million in 2022, then plummeted by 400.0% to -$5.0 million in 2023, then surged by 40.0% to -$3.0 million in 2024, then surged by 33.33% to -$2.0 million in 2025.
  • Its Gains from Investment Securities stands at -$2.0 million for Q4 2025, versus $2.0 million for Q3 2025 and $5.0 million for Q2 2025.